10-K Decoder · All companies

Whitehawk Therapeutics, Inc.

WHWK · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$7.14M$26.0M−72.5%
Operating income−$114M−$67.5M−69.6%
Net income−$20.6M−$63.7M+67.7%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 9, 2026

$Q3 2026Year earlierChange
Revenue$0K$0K
Operating income−$22.9M−$19.5M−17.4%
Net income−$21.2M−$17.7M−19.8%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Whitehawk's revenue in FY2025?
$7.14M in FY2025 (Fiscal year ended Dec 31, 2025), −72.5% vs $26.0M a year earlier, per its 10-K filed Mar 2026.
Was Whitehawk profitable in FY2025?
No: net income was −$20.6M and operating income −$114M in FY2025.
What was Whitehawk's revenue in Q3 2026?
$0K (n/a vs a year earlier), per its Form 10-Q filed Nov 9, 2026.